Description

SUSTEN 400 MG CAPS

Indications

SUSTEN 400 MG CAPS, which contains the active ingredient progesterone, is primarily indicated for the treatment of various conditions related to progesterone deficiency. These conditions include secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and as part of hormone replacement therapy in postmenopausal women. Additionally, SUSTEN is utilized in assisted reproductive technology protocols to support the luteal phase in women undergoing in vitro fertilization (IVF) and other fertility treatments.

Mechanism of Action

Progesterone, the active component of SUSTEN, is a natural steroid hormone that plays a crucial role in the menstrual cycle and pregnancy. It is secreted by the corpus luteum in the ovaries after ovulation and helps prepare the endometrium for potential implantation of a fertilized egg. SUSTEN acts by binding to progesterone receptors in target tissues, leading to a series of biological responses that promote the maintenance of pregnancy, regulate menstrual cycles, and modulate the effects of estrogen. This action helps to stabilize the endometrial lining and prevent excessive uterine contractions.

Pharmacological Properties

SUSTEN is a micronized formulation of progesterone, which enhances its bioavailability and absorption when administered orally. The pharmacokinetics of SUSTEN indicate that it has a peak plasma concentration within 3 to 4 hours post-administration. The half-life of progesterone is approximately 5 to 20 hours, depending on individual metabolism and other factors. SUSTEN is metabolized primarily in the liver, and its metabolites are excreted through urine. The pharmacological effects of progesterone include its anti-estrogenic properties, which help in counteracting the proliferative effects of estrogen on the endometrium, thus reducing the risk of endometrial hyperplasia.

Contraindications

SUSTEN 400 MG CAPS is contraindicated in patients with known hypersensitivity to progesterone or any of the excipients in the formulation. It should not be used in individuals with a history of thromboembolic disorders, such as deep vein thrombosis or pulmonary embolism, or in those with severe liver dysfunction. Additionally, SUSTEN is contraindicated in patients with undiagnosed vaginal bleeding, breast cancer, or other hormone-sensitive cancers, as well as in cases of missed abortion or ectopic pregnancy.

Side Effects

Like all medications, SUSTEN 400 MG CAPS may cause side effects. Common side effects include dizziness, headache, fatigue, and gastrointestinal disturbances such as nausea or diarrhea. Some women may experience breast tenderness or changes in menstrual flow. In rare cases, serious side effects may occur, including allergic reactions, severe abdominal pain, or signs of thromboembolic events such as swelling of the legs or chest pain. Patients should be advised to report any unusual or severe symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of SUSTEN 400 MG CAPS varies based on the indication and individual patient factors. For the management of secondary amenorrhea or abnormal uterine bleeding, the typical dosage is 200 to 400 mg daily, administered for 10 to 14 days per cycle. In the context of hormone replacement therapy, a common regimen may involve taking SUSTEN 200 mg daily for the last 12 to 14 days of a 28-day cycle. For patients undergoing assisted reproductive technology, SUSTEN may be prescribed at a dosage of 400 mg daily, starting after ovulation induction and continuing until the pregnancy test. It is essential to follow the prescribing physician’s instructions regarding dosage and duration of therapy.

Interactions

SUSTEN 400 MG CAPS may interact with other medications. It is known to enhance the effects of anticoagulants, which may increase the risk of bleeding. Additionally, certain medications that induce liver enzymes, such as rifampicin or phenobarbital, may reduce the effectiveness of progesterone by increasing its metabolism. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions. Monitoring may be necessary when SUSTEN is used concurrently with other drugs that affect hormonal levels or liver function.

Precautions

Before initiating treatment with SUSTEN 400 MG CAPS, a thorough medical history and physical examination should be conducted. Special caution is advised in patients with a history of cardiovascular disease, hypertension, or diabetes, as progesterone may exacerbate these conditions. Regular monitoring of blood pressure and glucose levels may be warranted during treatment. It is also important to assess for any signs of thromboembolic events, especially in patients with additional risk factors. Pregnant women should only use SUSTEN if the potential benefits outweigh the risks, and it should be avoided during breastfeeding unless deemed necessary by a healthcare provider.

Clinical Studies

Clinical studies have demonstrated the efficacy of SUSTEN in various indications. In a randomized controlled trial involving women with luteal phase defects, the use of SUSTEN significantly improved pregnancy rates compared to placebo. Another study highlighted its effectiveness in managing abnormal uterine bleeding, showing a reduction in bleeding episodes and improvement in quality of life. Long-term studies have also indicated that SUSTEN is well-tolerated, with a safety profile consistent with other progesterone formulations. These findings support the use of SUSTEN as a reliable option for patients requiring progesterone supplementation.

Conclusion

SUSTEN 400 MG CAPS is a valuable therapeutic option for managing conditions associated with progesterone deficiency. Its mechanism of action, pharmacological properties, and clinical efficacy make it suitable for a variety of indications, including secondary amenorrhea, abnormal uterine bleeding, and as part of fertility treatments. While generally well-tolerated, it is essential for patients to be aware of potential side effects and drug interactions. A thorough evaluation by a healthcare provider is crucial to ensure safe and effective use of SUSTEN in individual patients.